Search results
Results from the WOW.Com Content Network
Quest Diagnostics (NYSE: DGX) stock was teasing its all-time high on Thursday, no mean feat for a company that's been publicly traded for decades. The healthcare testing specialist's share price ...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the ...
Let's see if Quest Diagnostics Incorporated (DGX) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Quest Diagnostics (DGX) closed the most recent trading day at $118.40, moving -0.08% from the previous trading session. This move was narrower than the S&P 500's daily loss of 0.22%.
Stock name Symbol Country of origin Q2 Holdings, Inc. QTWO: US Qiagen N.V. QGEN: Netherlands: Quad/Graphics, Inc. QUAD: US Quaker Chemical Corporation: KWR: US Quanex Building Products Corporation NX: US Quanta Services Inc. PWR: US Quantum FinTech Acquisition Corporation QFTA: US Quantum FinTech Acquisition Corporation QFTA.UN: US QuantumScape ...
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Let's see if Quest Diagnostics (DGX) stock is a good choice for value-oriented investors right now from multiple angles.
Quest Diagnostics set a record in April 2009 when it paid $302 million to the government to settle a Medicare fraud case alleging the company sold faulty medical testing kits. It was the largest qui tam ( whistleblower ) settlement paid by a medical lab for manufacturing and distributing a faulty product. [ 53 ]